阿奇霉素静滴治疗支原体肺炎的临床效果

张涛

（西安儿童医院，陕西 西安，710003）

浏览次数：90次 下载次数：463次

摘要：

目的 探讨阿奇霉素静滴治疗支原体肺炎的临床效果。方法 选取于我院进行治疗的144例支原体肺炎患者为研究对象，将其随机分为治疗组和对照组，每组72例。治疗组患者采取阿奇霉素静滴治疗，对照组患者采取常规治疗。比较两组患者的临床治疗效果及不良反应发生情况。结果 治疗组患者治疗总有效率为93.06%，明显高于对照组患者的72.22%，差异具有统计学意义（P<0.05）。治疗组患者的不良反应发生率为4.17%，明显低于对照组患者的19.44%，差异具有统计学意义（P<0.05）。结论 阿奇霉素静滴治疗支原体肺炎临床效果显著，不良反应发生率低，值得临床推广使用。

关键词：阿奇霉素静滴；支原体肺炎；不良反应

中图分类号：R725.6文献标志码：A文章编号：2096-1413(2017)21-0088-02

Clinical effect of azithromycin intravenous drip in the treatment of mycoplasma pneumonia
ZHANG Tao
(Xi``an Children``s Hospital, Xi``an 710003, China)

ABSTRACT: Objective To investigate the clinical effect of azithromycin intravenous drip in the treatment of mycoplasma pneumonia. Methods A total of 144 cases of patients with mycoplasma pneumonia were selected as the study objects, all the patients were randomly divided into treatment group and control group, with 72 cases in each group. The treatment group was treated with azithromycin intravenous drip, and the control group was given routine treatment. The clinical effects and incidence of adverse reactions of the two groups were compared. Results The total effective rate of the treatment group was 93.06%, which was higher than 72.22% of the control group, the difference was statistically significant (P<0.05). The incidence rate of adverse reactions of the treatment group was 4.17%, which was lower than 19.44% of the control group, the difference was statistically significant (P<0.05). Conclusion The clinical effect of azithromycin intravenous drip in the treatment of mycoplasma pneumonia is significant, and the incidence rate of the adverse reactions is low. It is worthy of clinical application and popularization.
KEYWORDS: azithromycin intravenous drip; mycoplasma pneumonia; adverse reactions

参考文献：
[1] 何新,符春茹,黄玉,等.阿奇霉素治疗小儿支原体肺炎致胃肠道不良反应的防治[J].西南国防医药,2014,24(3):304-305.
[2] 罗钦宏,梁锦枝,黄艳琼,等.炎琥宁联合阿奇霉素治疗小儿支原体肺炎的疗效及安全性的Meta 分析[J].中成药,2014,20(4):702-709.
[3] 黄晓琳.中药内外合治联合阿奇霉素治疗儿童支原体肺炎临床研究[D].北京:北京中医药大学,2013.
[4] 朱玫,吴惠兰.两种大环内酯类抗生素治疗小儿支原体肺炎的成本/效果分析[J].临床药物治疗杂志,2016,14(3):67-69.
[5] 李忠娜.小儿肺炎支原体肺炎临床分析[D].河南:新乡医学院,2014.


[6] 何青.预见性治疗对阿奇霉素治疗儿童支原体肺炎药物不良反应的干预效应[J].中国继续医学教育,2015,7(14):144-145.
[7] 王慧,段培蓓.阿奇霉素致儿童消化道不良反应的治疗及护理进展[J].实用临床医药杂志,2015,19(18):200-202.
[8] 陈伟岗.阿奇霉素序贯疗法应用于小儿支原体肺炎治疗的临床效果观察[J].中国社区医师:医学专业,2013,15(5):161-162.